Virtu Financial LLC Sab Biotherapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023
BUY
$0.38 - $1.09 $3,755 - $10,772
9,883 Added 65.83%
24,897 $21,000
Q1 2023

May 01, 2023
BUY
$0.42 - $0.75 $6,305 - $11,260
15,014 New
15,014 $7,000
Q1 2022

May 17, 2022
SELL
$1.78 - $8.5 $27,374 - $130,721
-15,379 Closed
0 $0
Q4 2021

Feb 17, 2022
BUY
$7.3 - $11.24 $112,266 - $172,859
15,379 New
15,379 $120,000

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $111M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email